Taysha Gene Therapies News - TSHA

Company Name	Stock Ticker Symbol	Market	Type
Taysha Gene Therapies Inc	TSHA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.09	3.91%	2.39	16:02:01

Open Price	Low Price	High Price	Close Price	Prev Close
2.35	2.295	2.45	2.39	2.30

more quote information »

Recent News

Date	Time	Source	Heading
4/05/2024	08:00	GLOBE	Taysha Gene Therapies Announces Inducement Grant Under..
3/20/2024	13:30	APS	Another Biotech Steals The Show Following Major Clinical..
3/19/2024	16:01	GLOBE	Taysha Gene Therapies Reports Full Year 2023 Financial..
3/19/2024	07:27	IHMARKETNEWS	US Index Futures Decline Ahead of Federal Reserve Meeting,..
3/14/2024	16:26	GLOBE	Taysha Gene Therapies to Release Full-Year 2023 Financial..
3/01/2024	17:08	GLOBE	Taysha Gene Therapies Announces Inducement Grant Under..
2/29/2024	08:00	GLOBE	Taysha Gene Therapies Announces Updates to TSHA-102 Clinical..
2/15/2024	16:01	GLOBE	Taysha Gene Therapies Provides Update on Deprioritized..
2/09/2024	16:24	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/02/2024	08:00	GLOBE	Taysha Gene Therapies Announces Inducement Grant Under..
1/22/2024	08:00	GLOBE	Taysha Gene Therapies Announces Poster Presentation on..
1/10/2024	08:06	EDGAR2	Form 8-K - Current report
1/10/2024	08:00	GLOBE	Taysha Gene Therapies Announces First Pediatric Patient..
1/05/2024	08:00	GLOBE	Taysha Gene Therapies Announces Inducement Grant Under..
12/20/2023	16:21	EDGAR2	Form 8-K - Current report
12/20/2023	16:20	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
12/19/2023	07:30	PRNUS	Trinity Capital Inc. Provides $40 Million Term Loan to..
11/29/2023	08:00	GLOBE	Taysha Gene Therapies Announces Expanded Eligibility in..
11/15/2023	16:29	EDGAR2	Form 8-K - Current report
11/14/2023	16:47	EDGAR2	Form 8-K - Current report
11/14/2023	16:08	GLOBE	Taysha Gene Therapies Reports Third Quarter 2023 Financial..
11/07/2023	08:00	GLOBE	Taysha Gene Therapies to Release Third Quarter 2023..
11/03/2023	16:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	16:40	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/01/2023	16:02	EDGAR2	Form 8-K - Current report
10/24/2023	08:00	GLOBE	Taysha Gene Therapies Presents New Preclinical In-vitro Data..
10/10/2023	08:00	GLOBE	Taysha Gene Therapies Announces Two Poster Presentations on..
10/05/2023	07:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/26/2023	08:08	EDGAR2	Form 8-K - Current report
9/26/2023	08:00	GLOBE	Taysha Gene Therapies Announces Second Patient Dosed with..
9/21/2023	16:01	EDGAR2	Form PRE 14A - Other preliminary proxy statements
9/19/2023	16:52	DJN	Taysha Gene Therapies to End Development of TSHA-120 After..
9/19/2023	16:09	EDGAR2	Form 8-K - Current report
9/19/2023	16:01	GLOBE	Taysha Gene Therapies Provides Update on TSHA-120 Program in..
9/11/2023	16:01	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/11/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/30/2023	16:02	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/29/2023	07:00	EDGAR2	Form 8-K - Current report
8/25/2023	16:22	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/24/2023	08:52	DJN	Taysha Gets FDA Fast-Track for Rett Syndrome Treatment
8/24/2023	08:09	EDGAR2	Form 8-K - Current report
8/24/2023	08:00	GLOBE	Taysha Gene Therapies Announces Fast Track Designation..
8/14/2023	08:36	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	07:29	EDGAR2	Form 8-K - Current report
8/14/2023	07:02	GLOBE	Taysha Gene Therapies Reports Initial Clinical Data from..
8/14/2023	07:00	GLOBE	Taysha Gene Therapies Announces $150 Million Private..
8/04/2023	16:02	EDGAR2	Form 8-K - Current report
7/31/2023	08:05	EDGAR2	Form 8-K - Current report
7/31/2023	08:00	GLOBE	Taysha Gene Therapies Announces Positive Recommendation from..
6/28/2023	08:31	EDGAR2	Form 8-K - Current report